Cargando…
A Proposed Efficacious Treatment with Clioquinol (Zinc Ionophore) and Cabergoline (Prolactin Dopamine Agonist) for the Treatment of Terminal Androgen-independent Prostate Cancer. Why and How?
All cases of prostate cancer exhibit the hallmark condition of marked decrease in zinc in malignancy compared to the high zinc levels in the normal and benign prostate. There exists no reported corroborated case of prostate cancer in which malignancy exhibits the high zinc levels that exist in the n...
Autores principales: | Costello, Leslie C., Franklin, Renty B. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6392423/ https://www.ncbi.nlm.nih.gov/pubmed/30828702 |
Ejemplares similares
-
Zinc Ionophore (Clioquinol) Inhibition of Human ZIP1-Deficient Prostate Tumor Growth in the Mouse Ectopic Xenograft Model: A Zinc Approach for the Efficacious Treatment of Prostate Cancer
por: Franklin, Renty B., et al.
Publicado: (2016) -
Testosterone, prolactin, and oncogenic regulation of the prostate gland. A new concept: Testosterone-independent malignancy is the development of prolactin-dependent malignancy!
por: Costello, Leslie C., et al.
Publicado: (2018) -
Radiosensitization of clioquinol and zinc in human cancer cell lines
por: Lu, Shan, et al.
Publicado: (2018) -
Outcomes of assisted reproduction treatment after dopamine agonist -cabergoline- for prevention of ovarian hyper stimulation syndrome
por: Movahedi, Shohreh, et al.
Publicado: (2016) -
Chloroquine Is a Zinc Ionophore
por: Xue, Jing, et al.
Publicado: (2014)